New HCA platform for oncology

Published by Nathalie MAUBON on

As oncology is the first used in HCS, Perkin Elmer has developped new High Content Analysis Platform dedicted for Cancer Applications as you can see below:

source: http://www.businesswire.com/news/home/20140407005786/en/Content-Screening-Platform-Advances-High-Content-Analysis-Cancer#.U1OZnPl_tTw

Categories: HCS, HCA & Biology
Tags:

0 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Posts

Biomimesys

In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology

Few weeks ago, the Hong Kong–based company Insilico Medicine announced the beginning of a phase 1 clinical trial concerning a potential therapy for idiopathic pulmonary fibrosis. The event might have gone unnoticed but the way Read more…

HCS, HCA & Biology

The skin microbiota, a fundamental part of in vitro studies

The skin microbiota refers to the microorganisms living on the skin, on the surface of the epidermis, but also in the dermis and the hypodermis (Nakatsuji et al., 2013). On 1 cm2 of human skin, Read more…

HCS, HCA & Biology

Oxidative stress : definition and biological effects

Oxidative stress is a pathological state characterized by a cellular submergence by Reactive Oxygen Species (ROS) such as free radicals. ROS are naturally produced in small quantities by the cellular metabolism and used in physiological Read more…